# An Open-Label Extension Study of GA-GCB ERT in Patients With Type 1 Gaucher Disease

> **NCT00635427** · PHASE3 · COMPLETED · sponsor: **Shire** · enrollment: 95 (actual)

## Conditions studied

- Gaucher Disease, Type 1

## Interventions

- **BIOLOGICAL:** VPRIV®

## Key facts

- **NCT ID:** NCT00635427
- **Lead sponsor:** Shire
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-03-13
- **Primary completion:** 2012-12-28
- **Final completion:** 2012-12-28
- **Target enrollment:** 95 (ACTUAL)
- **Last updated:** 2021-06-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00635427

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00635427, "An Open-Label Extension Study of GA-GCB ERT in Patients With Type 1 Gaucher Disease". Retrieved via AI Analytics 2026-06-16 from https://api.ai-analytics.org/clinical/NCT00635427. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*